Peptide Science: An Independent Research Reference

Peptide science is the study of short chains of amino acids — typically 2 to 50 residues — and of everything that happens to those chains between design and measurement: synthesis, cleavage, purification, lyophilization, storage, reconstitution, and analytical verification. On this site the phrase is used narrowly and deliberately. We are interested in the chemistry and the documentation, not in human use. Every article here describes laboratory-research contexts only.

The reason documentation matters so much is that a peptide is invisible to the buyer. A vial of white lyophilized powder could be the labeled sequence at 99.2% purity, the same sequence at 84% purity, a truncated deletion sequence, or an entirely different compound. Nothing about the appearance distinguishes them. The only thing that does distinguish them is the certificate of analysis and the chromatogram behind it — which makes those documents the actual product. That single idea organizes everything we publish.

This pillar is the root of our peptide science cluster. Each section below summarizes one layer of the problem and links to a deeper article where the parameters, the arithmetic, and the failure modes are worked through in detail. If you are new to the field, read this page top to bottom once; afterwards, use it as a table of contents.

Nearly all research peptides shorter than roughly 50 residues are made by solid-phase peptide synthesis (SPPS). The chain is built residue by residue on an insoluble resin, with each cycle coupling one protected amino acid, capping unreacted sites, and deprotecting for the next cycle. After the final cleavage, the crude mixture contains the target peptide plus a predictable family of impurities: deletion sequences (missing one residue), incompletely deprotected sequences, oxidation products, and aspartimide-related adducts.

Those impurities are the reason purification exists. Preparative reverse-phase HPLC separates the target from its impurity family by hydrophobicity, and each collected fraction is then re-verified analytically before pooling. A synthesis claim without a purification and verification step behind it is not a purity claim at all — it is a hope with a percentage attached.

The practical consequence for a buyer of research peptides is that "synthesized in-house" means very little by itself. What matters is whether the vendor publishes batch-specific analytical data for the exact lot you receive, or only a representative chromatogram reused across lots. We cover this failure mode in detail in our gray market peptides analysis and in the quality cluster below.

Purity numbers are method-dependent, and comparing numbers measured by different methods is meaningless. Analytical reverse-phase HPLC with UV detection at 214 nm is the industry standard: it reports the area percentage of the main peak relative to all UV-absorbing species eluting in the run. LC-MS confirms the mass of each peak, which is what actually proves identity — HPLC alone cannot distinguish two species of identical retention.

Two related numbers are routinely confused with purity. Content (net peptide content) is the fraction of the vial's mass that is the peptide itself, as opposed to counter-ions, residual solvent, and adsorbed water; a 99% pure peptide can be 75% net content. Accuracy is the agreement between the stated and measured amount. A vial labeled "5 mg, ≥98%" is making three separate claims, and only one of them is about purity. We unpack these parameters and their arithmetic in high purity peptides and best quality peptides.

For comparing vendors, the useful questions are: measured by which method, on which batch, at which wavelength, and with what integration parameters? A vendor that answers those four questions in its documentation is behaving like a supplier; a vendor that answers with the word "pharmaceutical-grade" is behaving like a marketer.

A certificate of analysis is a data table, and like any data table it can be read competently or incompetently. The competent reading checks five things in order: (1) the lot number on the COA matches the lot number on the vial; (2) the method named is HPLC or UPLC with a stated wavelength; (3) the purity figure is an area percentage of the main peak, not a "typical" or "minimum" value; (4) a mass-spectrometry result confirms the molecular weight; (5) the appearance, net mass, and storage conditions are stated.

Then check what is missing. COAs that omit the lot link, show a chromatogram with no axis labels, or recycle the same chromatogram across different products are the gray market's signature artifact. We treat the absence of batch-specific data as the single most predictive red flag in this entire field — more predictive than price, web design, or review sentiment.

This is also why our vendor pages read the way they do. When we summarize a company such as Bachem or Core Peptides, we are summarizing what its public documentation does and does not show, not vouching for any product.

The powder in a research vial is never just peptide. After reverse-phase purification, the product is isolated as a salt — most commonly the trifluoroacetate (TFA) salt formed by the TFA used in the HPLC mobile phase. For every free amine on the molecule, a counter-ion rides along, and for short, highly basic peptides the counter-ion fraction can reach 10–15% of the total mass. Vendors that need a different salt form (acetate or chloride, the pharmacopoeial preference) must run an additional ion-exchange step, which costs money and appears in the documentation as a stated salt form.

This is why two vials both labeled "5 mg" can contain different amounts of actual peptide. A catalog house typically states net peptide content explicitly — 70–85% is normal for a TFA salt after accounting for water and residual solvent — while gray-market listings quote the gross fill weight and let the ambiguity work in the seller's favor. Multiplied across a price list, that single unstated parameter moves effective price by more than most advertised discounts. The full arithmetic, including worked per-milligram comparisons, is on our peptide price page.

Net content also interacts with purity in a way that surprises people: a "99% pure, 72% content" vial contains less target peptide per milligram than a "95% pure, 90% content" vial. Neither number alone tells you what you are holding. This is why our high purity peptides page insists that purity, content, and fill accuracy be reported together, and why a COA that reports only one of the three is telling you less than it appears to.

Lyophilized peptides are chemistry's small mercy: freeze-dried, sealed, and kept cold and dry, most sequences are stable for years. The enemy is water. Lyophilized powder is hygroscopic, and every humidity excursion invites hydrolysis and deamidation; a vial stored on a warm shelf in a humid room degrades measurably faster than the same vial at −20°C with desiccant. Repeated freeze-thaw cycling of reconstituted material is the other classic error — each cycle concentrates degradation at the air-water interface.

Once a peptide is dissolved, the clock changes. Reconstituted solutions are typically stable for days to a few weeks refrigerated, and months frozen in single-use aliquots — but the honest number is sequence-specific. Methionine and tryptophan oxidize; asparagine deamidates; acidic peptides adsorb to glass. Bacteriostatic water (with 0.9% benzyl alcohol) extends the refrigerated window for solution work, while sterile water does not. A seller who claims a universal "stable for 6 months reconstituted" without citing sequence-specific data is extrapolating beyond anything published.

For a research site, the practical takeaway is documentation again: a COA that states storage conditions and a retest date is describing a real supply chain; one that says nothing is describing a repackaging operation. We apply that lens throughout the quality cluster — see best quality peptides for how storage disclosures rank among quality signals.

In laboratory practice, the most common analytical error with peptides is arithmetic, not chemistry. Preparing a stock solution from a stated fill mass is simple division — 5 mg of peptide brought to 2.0 mL is a 2.5 mg/mL stock — but two corrections matter. First, correct for net content: if the COA says 76% net content, the true peptide concentration is 0.76 of the naive figure. Second, correct for purity if downstream quantitation assumes the main peak only. Skipping both corrections stacks a 20–40% systematic error into every solution prepared from the vial.

The same discipline applies to serial dilutions and to unit conversions between molarity and mass concentration. A 1 mM solution of a 1,000 Da peptide is 1 mg/mL; researchers who work across both unit systems should write the conversion into their protocol once, not re-derive it per preparation. None of this is human-use guidance — it is stock-solution preparation for analytical work, the same arithmetic any pharmacology or biochemistry bench uses, and it is the single highest-leverage skill in this field.

We walk through complete worked examples — content correction, purity correction, molar conversions, and aliquot planning — in the method pages of this cluster, including high purity peptides and the vendor-neutral comparison tables in catalog peptides.

HPLC with UV detection answers "how much of this mixture is the main peak," but three other methods answer questions HPLC cannot. Mass spectrometry (LC-MS or MALDI-TOF) answers "is the main peak the labeled molecule" by measuring molecular weight to sub-dalton accuracy — without it, a chromatogram proves retention time, not identity. Amino acid analysis (AAA), a workhorse of the catalog tier that the research tier almost never runs, answers "how much peptide mass is actually present" and is the method behind honest net-content figures. Karl Fischer titration answers "how much water is in the vial" — the difference between a peptide and a peptide plus a bad week of humidity.

Reading a vendor's documentation for which of these methods appear is a fast capability test. A COA bearing HPLC purity, an MS identity confirmation, and an AAA-derived content figure describes a real analytical workflow; a COA bearing one number and a stock image describes a marketing department. Wavelength choice is a subtler tell: 214 nm (peptide bond) is the standard, and 280 nm only works for sequences containing aromatic residues.

Our peptide science review methodology page grades published documentation on exactly this basis, and the same method-stack logic underpins the vendor profiles in our top peptide companies pillar.

The research-tier vocabulary of quality is borrowed from regulated contexts and used with the definitions left behind. "Pharmaceutical grade" has meaning only against a specific pharmacopoeia monograph and a specific GMP audit trail; applied to a research vial it means the speaker hopes you will associate the phrase with pharmacies. "USP grade" similarly references the United States Pharmacopeia, whose monographs cover some peptide drugs but not research chemicals. "Research grade" is at least honest, in that it promises only what the research tier delivers: variable documentation and no regulatory standing.

Even the honest-looking claims decode unevenly. "≥98% purity" should mean an HPLC main-peak area percentage on the lot you receive; in practice it is frequently a minimum spec quoted against a representative or historical chromatogram. "Third-party tested" should mean an independent laboratory received the lot and published the result; in practice it sometimes means the seller's supplier ran an in-house test. Each of our vendor pages notes which usage the company's own documents support.

The vocabulary that survives this decoding is small and precise: lot number, method, wavelength, area percentage, net content, salt form, and date. Our what are the best peptides page turns that vocabulary into a comparison framework, and our gray market peptides analysis shows how the borrowed vocabulary functions inside the market that misuses it most.

Form factor changes the chemistry problem. Lyophilized powder in a sealed vial is the most stable and most measurable form. Pre-mixed solutions trade stability for convenience and add a preservative question. Oral forms — the subject of our peptide pills and peptide capsules articles — face first-pass digestion, which is why most research peptides are not oral drugs, and why "oral peptide" consumer products are usually collagen fragments or delivery-system stories rather than the injectable sequences people assume.

Kits bundle a peptide with reconstitution supplies; our peptide kits page explains what belongs in a legitimate research kit and what a kit listing is actually telling you about the seller's intended customer. Catalog peptides — off-the-shelf sequences from established chemical suppliers — are covered in catalog peptides, where the pricing and documentation differences between catalog houses and research-chemical sites are laid out side by side.

A note on spelling: search interest in this field is split across variants such as peptides sciences, peptido, and plain misspellings of "peptide." This page is the canonical target for all of them. The science does not change with the spelling; the sellers' documentation habits do not either.

Research peptides sit in an unusual commercial position. A small number of companies supply genuine pharmaceutical API and catalog chemicals with full documentation; a much larger number of websites sell "research-use-only" peptides with uneven documentation, to a customer base whose actual use is often not research. That second population is the gray market, and it is where nearly all of the field's quality problems live.

We analyze it without moralizing and without pretending it away: in gray market peptides we describe the tiers, the pricing logic, the reuse of stock photography and COAs, and the specific regulatory language ("for research purposes only") that the entire market borrows from legitimate chemical supply. Our research purposes only page dissects that phrase itself, because understanding what it legally does and does not permit is the most useful single piece of literacy this market offers.

If you take one habit from this site, take this one: when a seller's claim cannot be checked against a batch document, mentally delete the claim. Everything else — price comparisons, company rankings, community sentiment — is downstream of that discipline.

Every substantive claim we publish carries an implicit tier: peer-reviewed literature, regulatory filings and pharmacopoeia standards, primary technical documentation (manufacturer application notes, published COAs), and finally community-reported information. Community reports — including the Reddit discussions we cover on pages like AOD 9604 Reddit — are treated as data about sentiment, never as proof of product quality.

We do not sell peptides, do not accept affiliate placements, and do not provide medical advice. Company pages summarize public information and are not endorsements; our editorial policy documents the process, and our disclaimer bounds the scope.